Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence.

Epidermal growth factor (EGF) receptor-mediated cell migration plays a vital role in invasion of many tumor types. EGF receptor ligands increase invasiveness in vivo, but it remains unclear how consequent effects on intrinsic cell motility behavior versus effects on extrinsic matrix properties integrate to result in net increase of translational speed and/or directional persistence of migration in a 3D environment. Understanding this convolution is important for therapeutic targeting of tumor invasion, as key regulatory pathways for intrinsic versus extrinsic effects may not be coincident. Accordingly, we have undertaken a quantitative single-cell imaging study of glioblastoma cell movement in 3D matrices and on 2D substrata across a range of collagen densities with systematic variation of protease-mediated matrix degradation. In 3D, EGF induced a mild increase in cell speed and a strong increase in directional persistence, the latter depending heavily on matrix density and EGF-stimulated protease activity. In contrast, in 2D, EGF induced a similarly mild increase in speed but conversely a decrease in directional persistence (both independent of protease activity). Thus, the EGF-enhanced 3D tumor cell migration results only partially from cell-intrinsic effects, with override of cell-intrinsic persistence decrease by protease-mediated cell-extrinsic reduction of matrix steric hindrance.

[1]  Andreas S. Beutler,et al.  Diffuse brain invasion of glioma cells requires β1 integrins , 1996 .

[2]  J. Hurley,et al.  Phospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signaling. , 2006, The EMBO journal.

[3]  Peter Friedl,et al.  Molecular mechanisms of cancer cell invasion and plasticity , 2006, The British journal of dermatology.

[4]  Y. Okada,et al.  ADAMs in cancer cell proliferation and progression , 2007, Cancer science.

[5]  M. Berger,et al.  Proteases and the Biology of Glioma Invasion , 2004, Journal of Neuro-Oncology.

[6]  James E Bear,et al.  Negative Regulation of Fibroblast Motility by Ena/VASP Proteins , 2000, Cell.

[7]  J. Segall,et al.  The great escape: when cancer cells hijack the genes for chemotaxis and motility. , 2005, Annual review of cell and developmental biology.

[8]  L. Matrisian,et al.  The other side of MMPs: Protective roles in tumor progression , 2007, Cancer and Metastasis Reviews.

[9]  Sean P. Palecek,et al.  Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness , 1997, Nature.

[10]  S. Leivonen,et al.  EGF‐R regulates MMP function in fibroblasts through MAPK and AP‐1 pathways , 2007, Journal of cellular physiology.

[11]  Elliot L. Elson,et al.  Interstitial Collagenase Is a Brownian Ratchet Driven by Proteolysis of Collagen , 2004, Science.

[12]  L G Griffith,et al.  Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. , 1999, Biophysical journal.

[13]  A. Wells EGF receptor. , 1999, The international journal of biochemistry & cell biology.

[14]  J. Hurley,et al.  Phospholipase Cγ/diacylglycerol‐dependent activation of β2‐chimaerin restricts EGF‐induced Rac signaling , 2006 .

[15]  Y. Yarden The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. , 2001, European journal of cancer.

[16]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[17]  Daniel J Brat,et al.  Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. , 2004, The international journal of biochemistry & cell biology.

[18]  M H Gail,et al.  The locomotion of mouse fibroblasts in tissue culture. , 1970, Biophysical journal.

[19]  Peter Friedl,et al.  Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.

[20]  D. Lauffenburger,et al.  A high-throughput migration assay reveals HER2-mediated cell migration arising from increased directional persistence. , 2006, Biophysical journal.

[21]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Sledge,et al.  Extracellular proteolysis and cancer: meeting summary and future directions. , 2003, Cancer research.

[23]  S. Ethier,et al.  Autocrine and Juxtacrine Effects of Amphiregulin on the Proliferative, Invasive, and Migratory Properties of Normal and Neoplastic Human Mammary Epithelial Cells* , 2006, Journal of Biological Chemistry.

[24]  Peter Friedl,et al.  Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.

[25]  W. Broaddus,et al.  The Role of Matrix Metalloproteinase Genes in Glioma Invasion: Co-dependent and Interactive Proteolysis , 2001, Journal of Neuro-Oncology.

[26]  Y. Okada,et al.  The role of matrix metalloproteinases in glioma invasion. , 2003, Frontiers in bioscience : a journal and virtual library.

[27]  Douglas A Lauffenburger,et al.  Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions. , 2008, Biophysical journal.

[28]  J. Daniel,et al.  Biosynthesis of type VI collagen by glioblastoma cells and possible function in cell invasion of three-dimensional matrices. , 1995, Connective tissue research.

[29]  D. Lauffenburger,et al.  Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Broaddus,et al.  Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. , 2004, Neuro-oncology.

[31]  Douglas A. Lauffenburger,et al.  Understanding Effects of Matrix Protease and Matrix Organization on Directional Persistence and Translational Speed in Three-Dimensional Cell Migration , 2006, Annals of Biomedical Engineering.

[32]  D. Louis,et al.  Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors. , 2005, Cancer research.

[33]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[34]  X. Bian,et al.  Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. , 2007, Cancer research.

[35]  A. Wells,et al.  DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. , 2004, Experimental cell research.

[36]  N. Hacker,et al.  Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. , 2001, Journal of the National Cancer Institute.

[37]  F. Spinella,et al.  Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. , 2007, Cancer research.

[38]  Kenji Tada,et al.  Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. , 2003, Cancer research.

[39]  Erez M. Bublil,et al.  The EGF receptor family : spearheading a merger of signaling and therapeutics , 2007 .

[40]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[41]  Jiahua Xu,et al.  Rac1 Mediates Type I Collagen-dependent MMP-2 Activation , 2001, The Journal of Biological Chemistry.

[42]  F. White,et al.  Uncovering Therapeutic Targets FOR Glioblastoma: A Systems Biology Approach , 2007, Cell cycle.

[43]  Alan Wells,et al.  Growth Factor-Induced Cell Motility in Tumor Invasion , 2002, Acta oncologica.

[44]  M. Westphal,et al.  Inhibition of Glioblastoma Angiogenesis and Invasion by Combined Treatments Directed Against Vascular Endothelial Growth Factor Receptor-2, Epidermal Growth Factor Receptor, and Vascular Endothelial-Cadherin , 2005, Clinical Cancer Research.

[45]  A. Wells,et al.  Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.

[46]  D A Lauffenburger,et al.  Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. , 1998, Journal of cell science.

[47]  M. Stack,et al.  Proteinase requirements of epidermal growth factor–induced ovarian cancer cell invasion , 1998, International journal of cancer.

[48]  M. Berens,et al.  Molecular targets of glioma invasion , 2007, Cellular and Molecular Life Sciences.

[49]  J. Koziol,et al.  Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix , 2004, Stroke.

[50]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[51]  J. Condeelis,et al.  The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration , 2007, Journal of Cell Science.

[52]  G. Riggins,et al.  Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. , 2002, Cancer research.

[53]  Sean P. Palecek,et al.  Erratum: Integrin–ligand binding properties govern cell migration speed through cell–substratum adhesiveness , 1997, Nature.

[54]  M. Stack,et al.  Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion , 2007, Nature Cell Biology.

[55]  Richard B. Dickinson,et al.  Optimal estimation of cell movement indices from the statistical analysis of cell tracking data , 1993 .

[56]  Yukinori Endo,et al.  A Rac switch regulates random versus directionally persistent cell migration , 2005, The Journal of cell biology.

[57]  Douglas A Lauffenburger,et al.  Directional persistence of EGF-induced cell migration is associated with stabilization of lamellipodial protrusions. , 2005, Biophysical journal.

[58]  C. Gladson The extracellular matrix of gliomas: modulation of cell function. , 1999, Journal of Neuropathology and Experimental Neurology.

[59]  G. Pilkington,et al.  The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells , 1999, British Journal of Cancer.

[60]  M. Seiki,et al.  MT-MMPs play pivotal roles in cancer dissemination , 2004, Clinical & Experimental Metastasis.

[61]  David F Meaney,et al.  Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures. , 2006, Biophysical journal.

[62]  W. Paulus,et al.  Diffuse brain invasion of glioma cells requires beta 1 integrins. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[63]  C. Waterman-Storer,et al.  Spatiotemporal Feedback between Actomyosin and Focal-Adhesion Systems Optimizes Rapid Cell Migration , 2006, Cell.

[64]  Dunn Ga,et al.  Characterising a kinesis response: time averaged measures of cell speed and directional persistence. , 1983 .

[65]  D. Lauffenburger,et al.  Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells , 2008, Molecular Pharmacology.